🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
For six hours following drug administration, subjects will rate the severit...
Status
Completed
Location
Universidad Autonoma de Guadalajara
Start Date
2008-10
Trial ID
NCT00685607
Treatments Being Tested
On the basis of Xiashi skin surgery clinical experience, this project adopt...
Status
Unknown
Location
Multiple Locations
Start Date
2015-08
Trial ID
NCT02517957
Treatments Being Tested
In a previous study azithromycin proved as efficacious as levofloxacin in t...
Status
Completed
Location
University of Texas Enteric Disease Research Clinics
Start Date
2002-06
Trial ID
NCT00359970
Treatments Being Tested
A Randomized Phase II Study to Evaluate the Incidence of Discontinuations d...
Status
Active Not Recruiting
Location
Hospital General Universitario de Elche
Start Date
2022-08-31
Trial ID
NCT05252988
Treatments Being Tested
This is a randomized, multicenter, phase II clinical trial evaluating proph...
Status
Recruiting
Location
Yale University
Start Date
2026-08-15
Trial ID
NCT07426822
Treatments Being Tested
This study will enroll up to 60 adults (including 30 females and 30 males) ...
Status
Active Not Recruiting
Location
University of Pennsylvania, Perelman School of Medicine
Start Date
2022-09-20
Trial ID
NCT05528848
Treatments Being Tested
Background: The new drug LMP744 (NSC 706744) damages deoxyribonucleic acid...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-02-27
Trial ID
NCT03030417
The goal of this clinical trial is to examine immune responses to the BCG v...
Status
Recruiting
Location
South Australian Health and Medical Research Institute
Start Date
2023-11-23
Trial ID
NCT06148025
Aim of the study The aim of this study is to use Gabbroral® oral tablet for...
Status
Unknown
Location
Gasthuisberg
Start Date
2013-02
Trial ID
NCT01780909
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Terminated
Location
UCSF Helen Diller Family Comprehensive Cancer Center
Start Date
2007-01
Trial ID
NCT00387894
Treatments Being Tested